Sex differences in the progression to Alzheimer's disease: a combination of functional and structural markers

Geroscience. 2024 Apr;46(2):2619-2640. doi: 10.1007/s11357-023-01020-z. Epub 2023 Dec 18.

Abstract

Mild cognitive impairment (MCI) has been frequently interpreted as a transitional phase between healthy cognitive aging and dementia, particularly of the Alzheimer's disease (AD) type. Of note, few studies explored that transition from a multifactorial perspective, taking into consideration the effect of basic factors such as biological sex. In the present study 96 subjects with MCI (37 males and 59 females) were followed-up and divided into two subgroups according to their clinical outcome: "progressive" MCI (pMCI = 41), if they fulfilled the diagnostic criteria for AD at the end of follow-up; and "stable" MCI (sMCI = 55), if they remained with the initial diagnosis. Different markers were combined to characterize sex differences between groups, including magnetoencephalography recordings, cognitive performance, and brain volumes derived from magnetic resonance imaging. Results indicated that the pMCI group exhibited higher low-frequency activity, lower scores in neuropsychological tests and reduced brain volumes than the sMCI group, being these measures significantly correlated. When sex was considered, results revealed that this pattern was mainly due to the influence of the females' sample. Overall, females exhibited lower cognitive scores and reduced brain volumes. More interestingly, females in the pMCI group showed an increased theta activity that correlated with a more abrupt reduction of cognitive and volumetric scores as compared with females in the sMCI group and with males in the pMCI group. These findings suggest that females' brains might be more vulnerable to the effects of AD pathology, since regardless of age, they showed signs of more pronounced deterioration than males.

Keywords: Alzheimer’s disease; Brain volumes; Cognition; Mild cognitive impairment; Neurophysiological activity; Sex differences.

MeSH terms

  • Alzheimer Disease*
  • Brain / diagnostic imaging
  • Brain / pathology
  • Disease Progression
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Sex Characteristics